pefloxacin has been researched along with Community Acquired Infection in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, CC; Ng, A; Poh, SC; Wang, YT; Yap, JC | 1 |
DvoretskiÄ, LI; Iakovlev, SV; Shakhova, TV; Suvorova, MP | 1 |
2 trial(s) available for pefloxacin and Community Acquired Infection
Article | Year |
---|---|
Evaluation of the efficacy of sequential intravenous-oral administration of pefloxacin in community-acquired lower respiratory tract infections in patients with underlying conditions.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Infective Agents; Community-Acquired Infections; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Male; Middle Aged; Pefloxacin; Respiratory Tract Infections; Treatment Outcome | 1995 |
[Program of empirical antibacterial therapy of community-acquired pneumonia].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftibuten; Cefuroxime; Cephalosporins; Community-Acquired Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Male; Middle Aged; Pefloxacin; Pneumonia, Bacterial; Roxithromycin; Spiramycin | 1998 |